Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hansoh Pharma
Biotech
Hansoh signs $690M ADC pact with fellow Chinese biotech Biotheus
Hansoh has secured a license to use Biotheus’ bispecific antibody PM1080/HS-20117 in developing antibody-drug conjugates.
James Waldron
Mar 15, 2024 8:35am
GSK heads back to Hansoh, paying $185M upfront for another ADC
Dec 20, 2023 9:01am
GSK pays $85M cash for China biotech's ADC
Oct 20, 2023 1:19pm
Chinese powerhouse continues charge into siRNA with Silence pact
Oct 15, 2021 7:15am
You want discount drugs? EQRx wants $1.8B first via SPAC deal
Aug 6, 2021 10:50am
EQRx bags rights to EGFR inhibitor to drive discount me-too plan
Jul 23, 2020 9:00am
